Redwood AI Corp. Signs LOI for AI-Enabled Pathogen Surveillance Initiative in East Africa

Redwood AI Corp. has signed a non-binding letter of intent to develop a regional pathogen tracking and AI-enabled outbreak intelligence initiative in Central and East Africa, aiming to enhance early detection of infectious disease threats.

Houston Metrowire Staff
Technology
Redwood AI Corp. Signs LOI for AI-Enabled Pathogen Surveillance Initiative in East Africa

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) announced the signing of a non-binding letter of intent with Dr. Placide Sesonga of the University of Global Health Equity in Rwanda to explore the development of a regional pathogen tracking and AI-enabled outbreak intelligence initiative across Central and East Africa. The proposed collaboration would focus initially on surveillance regions and mobility corridors in Rwanda and the Democratic Republic of the Congo, combining pathogen monitoring, genomic sequencing, geospatial analytics and Redwood’s AI-driven predictive intelligence platform to support earlier detection of emerging infectious disease threats.

The parties plan to develop project protocols, deployment frameworks and stakeholder engagement strategies while pursuing potential funding opportunities. This initiative underscores the growing importance of artificial intelligence in public health surveillance, particularly in regions vulnerable to infectious disease outbreaks. By leveraging Redwood’s AI platform, the project aims to provide predictive intelligence that could enable faster response times and more effective containment strategies.

Separately, Redwood announced the resignation of Graydon Bensler from its board of directors, effective immediately. The company did not provide further details regarding the resignation. Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI’s platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications.

For more information, visit https://ibn.fm/4ra9u for the full press release. The latest news and updates relating to RDWCF are available in the company’s newsroom at https://ibn.fm/RDWCF.

Blockchain Registration

QR Code for Blockchain Registration